Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
US Army
Fish and Richardson
Mallinckrodt
McKinsey
Colorcon
Healthtrust
Cantor Fitzgerald
Teva

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,283,369

« Back to Dashboard

Summary for Patent: 8,283,369
Title:Compounds and compositions and methods of use
Abstract: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
Inventor(s): Quart; Barry D. (Encinitas, CA), Girardet; Jean-Luc (San Diego, CA), Gunic; Esmir (San Diego, CA), Yeh; Li-Tain (Irvine, CA)
Assignee: Ardea Biosciences. Inc. (San Diego, CA)
Application Number:13/174,522
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 8,283,369

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-001 Aug 18, 2017 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-002 Aug 18, 2017 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ironwood Pharms Inc ZURAMPIC lesinurad TABLET;ORAL 207988-001 Dec 22, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe ACHIEVING A THERAPEUTIC BENEFIT IN A SUBJECT WITH GOUT ➤ Subscribe
Ironwood Pharms Inc ZURAMPIC lesinurad TABLET;ORAL 207988-001 Dec 22, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF GOUT ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,283,369

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,344,012 Compounds, compositions and methods of using same for modulating uric acid levels ➤ Subscribe
8,084,483 Compounds and compositions and methods of use ➤ Subscribe
8,633,232 Compounds, compositions and methods of using same for modulating uric acid levels ➤ Subscribe
8,173,690 Compounds, compositions and methods of using same for modulating uric acid levels ➤ Subscribe
8,357,713 Compounds and compositions and methods of use ➤ Subscribe
8,242,154 Compounds, compositions and methods of using same for modulating uric acid levels ➤ Subscribe
8,193,234 Compounds, compositions and methods of using same for modulating uric acid levels ➤ Subscribe
8,546,437 Compounds and compositions and methods of use ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,283,369

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 102826 ➤ Subscribe
Taiwan 201018463 ➤ Subscribe
Taiwan I415840 ➤ Subscribe
Taiwan 200927733 ➤ Subscribe
Taiwan I377200 ➤ Subscribe
Taiwan 201022216 ➤ Subscribe
Tunisia 2010000237 ➤ Subscribe
Slovenia 2217577 ➤ Subscribe
Singapore 183721 ➤ Subscribe
Serbia 53569 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Mallinckrodt
Citi
UBS
AstraZeneca
Argus Health
Harvard Business School
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot